Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ann Arbor, MI
SEC filing record 1 source field available
Fiscal year end
31 December
Esperion Therapeutics, Inc. has filed 952 SEC EDGAR filings since 07 May 2008

SEC filing history

Showing 151-175 of 179 matching filings.

Per page
25
Current page
7
8-K File 001-35986

8-K

Filing date
20 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
19 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
17 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
05 Mar 2015
Reporting date
05 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
02 Feb 2015
Reporting date
02 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
12 Jan 2015
Reporting date
12 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
10 Nov 2014
Reporting date
10 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
16 Oct 2014
Reporting date
14 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
14 Oct 2014
Reporting date
14 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
01 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
12 Aug 2014
Reporting date
12 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
31 Jul 2014
Reporting date
28 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
24 Jul 2014
Reporting date
24 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
02 Jul 2014
Reporting date
30 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
26 Jun 2014
Reporting date
23 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
19 May 2014
Reporting date
15 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
12 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
07 Mar 2014
Reporting date
05 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
28 Feb 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
14 Feb 2014
Reporting date
10 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
07 Feb 2014
Reporting date
04 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
13 Jan 2014
Reporting date
07 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
22 Nov 2013
Reporting date
18 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35986

8-K

Filing date
06 Nov 2013
Reporting date
06 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .